3 Biotech stocks winning the corona virus race

 In Uncategorized

There are quite a few companies out there that have profited from the corona virus  pandemic, but there are very few who are about to explode over it.

Here are the top 3 picks:
1. GILD – GILEAD SCIENCES
Was one of the pioneers to announce work on potential treatments.
REMDESIVIR a drug which was a prime candidate to treat Ebola has showed promising results in mitigating symptoms in patients with Coronoa virus.
Over the last month, Remdesivir has started a 2 stage project in China.
2 more late stage trials in Asia and finally one final trial in the US are waiting for health authorities final approval.
2. HOLX – HOLOGIC BIOMEDICAL DIAGNOSTICS COMPANY
600.000 corona virus test kits have been produced and shipped out all over the US.
The company was the first one to receive an emergency use authorization on Monday from the FDA and announced a daily production of 1.150 test kits a day has started.
3. REGN – REGENERON PHARMACEUTICALS
Kevzara, a drug which is designed to reduce the level of inflammation  response seen in corona virus patients helping to slow down and reduce symptoms.
DISCLAIMER: All trades are published under trading idea & tradingacademy.io holds no responsibility for trading our analysis.
Recent Posts

Leave a Comment

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt